跳至主要内容
临床试验/CTRI/2020/02/023545
CTRI/2020/02/023545尚未招募2 期

Efficacy of Darvyadhi lauha in the management of Hepatocellular jaundice (kamala) and hepatoprotective activity in paracetamol induced hepatotoxicity.

All India institute of Ayurveda0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • a) Diagnosed by elevated bilirubin (Conjugated) in liver function test >1 mg/dl(17 micro mol/L)
  • b) Age :18-50
  • c) Sex ; either male or female
  • d) Greenish yellow discolouration of skin,sclera ,nails and buccal mucosa(haridra twak ,netra ,nakha,anana)
  • e) Reddish yellow faecal matter and urine(Rakta peeta sakrut mutra)
  • f) Burning sensation (Daha)
  • g) Indigestion(Avipaka)
  • h) Lethargy(Dourbalya)
  • i) Fatigue(Sadana)
  • j) Aruchi(Loss of taste)

排除标准

  • 1)Age below 18 years and above 50 years of either sex.
  • 2)Pregnancy
  • 3)Obstructive jaundice
  • 4)Auto immune hepatitis
  • 5)Hepatocellular Carcinoma
  • 6)Liver Transplantation or Any other Condition Interfering with the result of the treatment.
  • 7)Thalassemia major, Sickle cell Disease other haemolytic Jaundices
  • 8)Ca -head of pancreas
  • 9)Gilbertâ??s Syndrome
  • 10)Patients having history of Chronic HTN&DM

研究者

相似试验